GlassScriptPhysician profile
Sofya B Tsyganovskaya
NPI 1336204312
$1,117.45
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $332 · 2020: $158 · 2021: $411 · 2022: $217.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $441.84 | 2019-2022 | |
| Allergan, INC. | $111.98 | 2019-2020 | |
| Therapeuticsmd, INC. | $103.14 | 2019-2021 | |
| Mayne Pharma Commercial LLC | $73.90 | 2021-2022 | |
| Agile Therapeutics, INC. | $69.65 | 2021-2022 | |
| Lupin INC. | $68.73 | 2019-2021 | |
| Myovant Sciences INC. | $61.14 | 2022 | |
| Pfizer INC. | $55.18 | 2020 | |
| Hologic Sales and Service, LLC | $32.18 | 2022 | |
| Evofem Biosciences, INC. | $29.30 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $24.22 | 2021 | |
| Amag Pharmaceuticals, INC. | $21.41 | 2019 | |
| Avion Pharmaceuticals | $13.56 | 2019 | |
| Exeltis, USA INC. | $11.22 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sofya Tsyganovskaya listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.